EC Number |
Inhibitors |
Structure |
---|
3.4.22.B62 | (2E)-N'-(2-[(naphthalen-1-ylmethyl)sulfanyl]acetyl)-3-phenylprop-2-enehydrazide |
- |
|
3.4.22.B62 | 2-([4-benzyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl)-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one |
- |
|
3.4.22.B62 | 4-(2,5-dimethyl-1H-pyrrol-1-yl)-N'-(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)benzohydrazide |
- |
|
3.4.22.B62 | 4-[4-(benzyloxy)phenyl]-3-([(4-methylphenyl)methyl]sulfanyl)-4,5-dihydro-1H-1,2,4-triazol-5-one |
- |
|
3.4.22.B62 | E-64 |
- |
|
3.4.22.B62 | N1-[3,5-bis(trifluoromethyl)phenyl]-N2-(1-ethynylcyclohexyl)benzene-1,2-dicarboxamide |
- |
|
3.4.22.B62 | Z-Phe-Ala-CHN2 |
- |
|
3.4.22.B62 | (6,7-difluoro-3-methyl-1,4-dioxidoquinoxalin-2-yl)(phenyl)methanone |
17% inhibiton at 0.01 mM |
|
3.4.22.B62 | 6-[(E)-[(2Z)-[4-(4-chlorophenyl)-3-(prop-2-en-1-yl)-1,3-thiazol-2(3H)-ylidene]hydrazinylidene]methyl]-2,3-dimethylquinoxaline 1,4-dioxide |
2% inhibiton at 0.01 mM |
|
3.4.22.B62 | (2Z)-2-[(2E)-[(2,3-dimethyl-1,4-dioxidoquinoxalin-6-yl)methylidene]hydrazinylidene]-3-(prop-2-en-1-yl)-1,3-thiazolidin-4-one |
22% inhibiton at 0.01 mM |
|